Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability
- PMID: 32635826
- DOI: 10.1177/1010428320938492
Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability
Abstract
Molecular classification of colorectal cancer is difficult to implement in clinical settings where hundreds of genes are involved, and resources are limited. This study aims to characterize the molecular subtypes of patients with sporadic colorectal cancer based on the three main carcinogenic pathways microsatellite instability (MSI), CpG island methylator phenotype (CIMP), and chromosomal instability (CIN) in a Chilean population. Although several reports have characterized colorectal cancer, most do not represent Latin-American populations. Our study includes 103 colorectal cancer patients who underwent surgery, without neoadjuvant treatment, in a private hospital between 2008 and 2017. MSI, CIN, and CIMP status were assessed. Frequent mutations in KRAS, BRAF, and PIK3CA genes were analyzed by Sanger sequencing, and statistical analysis was performed by Fisher's exact and/or chi-square test. Survival curves were estimated with Kaplan-Meier and log-rank test. Based on our observations, we can classify the tumors in four subgroups, Group 1: MSI-high tumors (15%) are located in the right colon, occur at older age, and 60% show a BRAF mutation; Group 2: CIN-high tumors (38%) are in the left colon, and 26% have KRAS mutations. Group 3: [MSI/CIN/CIMP]-low/negative tumors (30%) are left-sided, and 39% have KRAS mutations; Group 4: CIMP-high tumors (15%) were more frequent in men and left side colon, with 27% KRAS and 7% presented BRAF mutations. Three percent of patients could not be classified. We found that CIMP-high was associated with a worse prognosis, both in MSI-high and MSI stable patients (p = 0.0452). Group 3 (Low/negative tumors) tend to have better overall survival compared with MSI-high, CIMP-high, and CIN-high tumors. This study contributes to understanding the heterogeneity of tumors in the Chilean population being one of the few characterizations performed in Latin-America. Given the limited resources of these countries, these results allow to improve molecular characterization in Latin-American colorectal cancer populations and confirm the possibility of using the three main carcinogenic pathways to define therapeutic strategies.
Keywords: CIMP; CIN; CRC; Colorectal cancer; Latin-America; MSI; carcinogenesis.
Similar articles
-
Methylator phenotype in colorectal cancer: A prognostic factor or not?Crit Rev Oncol Hematol. 2016 Mar;99:74-80. doi: 10.1016/j.critrevonc.2015.11.001. Epub 2015 Dec 7. Crit Rev Oncol Hematol. 2016. PMID: 26702883 Review.
-
Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women.Gastroenterology. 2013 Aug;145(2):348-56.e1-2. doi: 10.1053/j.gastro.2013.05.001. Epub 2013 May 7. Gastroenterology. 2013. PMID: 23665275 Free PMC article.
-
Four molecular subtypes of colorectal cancer and their precursor lesions.Arch Pathol Lab Med. 2011 Jun;135(6):698-703. doi: 10.5858/2010-0523-RA.1. Arch Pathol Lab Med. 2011. PMID: 21631262 Review.
-
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?BMC Cancer. 2008 Sep 9;8:255. doi: 10.1186/1471-2407-8-255. BMC Cancer. 2008. PMID: 18782444 Free PMC article.
-
The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.Gastroenterology. 2007 Jan;132(1):127-38. doi: 10.1053/j.gastro.2006.09.018. Epub 2006 Sep 20. Gastroenterology. 2007. PMID: 17087942
Cited by
-
Distinct Driver Pathway Enrichments and a High Prevalence of TSC2 Mutations in Right Colon Cancer in Chile: A Preliminary Comparative Analysis.Int J Mol Sci. 2024 Apr 25;25(9):4695. doi: 10.3390/ijms25094695. Int J Mol Sci. 2024. PMID: 38731914 Free PMC article.
-
G-Protein Signaling Modulator 2 as a Potential Biomarker in Colorectal Cancer: Integrative Analysis Using Genetic Profiling and Pan-Cancer Studies.Genes (Basel). 2024 Apr 9;15(4):474. doi: 10.3390/genes15040474. Genes (Basel). 2024. PMID: 38674408 Free PMC article.
-
Preoperative prediction of microsatellite instability status in colorectal cancer based on a multiphasic enhanced CT radiomics nomogram model.BMC Med Imaging. 2024 Apr 2;24(1):77. doi: 10.1186/s12880-024-01252-1. BMC Med Imaging. 2024. PMID: 38566000 Free PMC article.
-
Genetic heterogeneity of colorectal cancer and the microbiome.World J Gastrointest Oncol. 2023 Mar 15;15(3):443-463. doi: 10.4251/wjgo.v15.i3.443. World J Gastrointest Oncol. 2023. PMID: 37009315 Free PMC article. Review.
-
Systems biology and OMIC data integration to understand gastrointestinal cancers.World J Clin Oncol. 2022 Oct 24;13(10):762-778. doi: 10.5306/wjco.v13.i10.762. World J Clin Oncol. 2022. PMID: 36337313 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous